BPC-157 is NOT suitable for individuals with: Active cancer (as it promotes new blood vessel growth)
Use only pharmaceutical-grade material from a licensed source
Concerns about potential safety and efficacy issues have turned the peptide into a kind of gray-market celebrity, where consumer safety and efficacy are almost certainly a risk
B12 therapy requires the same kind of regular check-ins to stay effective
This solution is intended solely to support standardized preparation procedures during non-clinical, experimental research activities
Systemic side effects may include nausea, gastrointestinal upset, flushing, and, in rare cases, allergic reactions such as rash, hives, or anaphylaxis